Hyp9
Hyp9 is a transient receptor potential canonical 6 (TRPC6) -specific agonist. Hyp9 can be used for the research of spinal cord injury (SCI) [1].
Product Specifications
CAS Number
3118-34-1
UNSPSC
12352005
Target
TRP Channel
Type
Natural Products
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/hyp9.html
Concentration
10mM
Purity
99.90
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(CCCCC)C1=C(C=C(C(C(CCCCC)=O)=C1O)O)O
Molecular Formula
C18H26O5
Molecular Weight
322.40
References & Citations
[1]Jiajun Cai, et al. Upregulation of TRPC6 inhibits astrocyte activation and proliferation after spinal cord injury in rats by suppressing AQP4 expression. Brain Res Bull. 2022 Nov;190:12-21.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![ERK2 Mouse Monoclonal Antibody [A10D2]](https://cdn.genprice.uk/products/992/68dd1c8a061270361ea81047/imageurl/em1901-54.webp)
